United Therapeutics Corporation UTHR
$551.00
▲ +0.10% 24H
About
United Therapeutics Corporation is a biotechnology company specializing in therapies for pulmonary arterial hypertension (PAH), pulmonary hypertension associated with interstitial lung disease, and other serious conditions. Founded in 1996 and headquartered in Silver Spring, Maryland, the company operates as a public b…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees1,400
TickerUTHR
Statistics
Market Cap$23.23B
Revenue (TTM)$3.18B
Net Income$1.33B
Net Margin41.9%
EPS$27.86
P/E20.17
P/S7.30
P/B3.90
EV/EBITDA13.56
ROE20.3%
Dividend Yield—
Price$551.00
Data: Twelve Data · Revenue = mcap / P/S